Rare Victory For Generic Drug Industry In Patent Ruling
By Erik Larson ( January 18, 2006, 12:00 AM EST) -- Pharmaceutical giant AstraZeneca has lost a key U.S. court ruling concerning two patents covering the heart drug Toprol-XL in the latest setback in the company's struggle to sustain its pipeline of blockbuster medications....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.